Related references
Note: Only part of the references are listed.Manipulation of Glycolysis in Malignant Tumors: Fantasy or Therapy?
U. G. A. Sattler et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer
R. J. DeBerardinis et al.
ONCOGENE (2010)
Co-localisation of hypoxia and perfusion markers with parameters of glucose metabolism in human squamous cell carcinoma (hSCC) xenografts
Ala Yaromina et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2009)
Tumor cell metabolism: Cancer's Achilles' heel
Guido Kroemer et al.
CANCER CELL (2008)
Hyperpolarized 13C Lactate, Pyruvate, and Alanine: Noninvasive Biomarkers for Prostate Cancer Detection and Grading
Mark J. Albers et al.
CANCER RESEARCH (2008)
New approaches for imaging tumour responses to treatment
Kevin Brindle
NATURE REVIEWS CANCER (2008)
Lung carcinoma: Diffusion-weighted MR imaging - Preliminary evaluation with apparent diffusion coefficient
Munetaka Matoba et al.
RADIOLOGY (2007)
Tumor lactate content predicts for response to fractionated irradiation of human squamous cell carcinomas in nude mice
Verena Quennet et al.
RADIOTHERAPY AND ONCOLOGY (2006)
p53 regulates mitochondrial respiration
Satoaki Matoba et al.
SCIENCE (2006)
EGFR tyrosine kinase inhibitors decrease VEGF expression by both hypoxia-inducible factor (HIF)-1-independent and HIF-1-dependent mechanisms
N Pore et al.
CANCER RESEARCH (2006)
Mitochondrial tumour suppressors: A genetic and biochemical update
E Gottlieb et al.
NATURE REVIEWS CANCER (2005)
HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: Novel role of fumarate in regulation of HIF stability
JS Isaacs et al.
CANCER CELL (2005)
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase
MA Selak et al.
CANCER CELL (2005)
Lactate in solid malignant tumors: Potential basis of a metabolic classification in clinical oncology
S Walenta et al.
CURRENT MEDICINAL CHEMISTRY (2004)
Lactate: Mirror and motor of tumor malignancy
S Walenta et al.
SEMINARS IN RADIATION ONCOLOGY (2004)
Why do cancers have high aerobic glycolysis?
RA Gatenby et al.
NATURE REVIEWS CANCER (2004)
Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis
MI Koukourakis et al.
BRITISH JOURNAL OF CANCER (2003)
Metabolic classification of human rectal adenocarcinomas: a novel guideline for clinical oncologists?
S Walenta et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2003)
Mitochondrial impairment in p53-deficient human cancer cells
S Zhou et al.
MUTAGENESIS (2003)
Dominant-negative hypoxia-inducible factor-1α reduces tumorigenicity of pancreatic cancer cells through the suppression of glucose metabolism
J Chen et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis
HS Lu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Metabolic mapping with bioluminescence: basic and clinical relevance
S Walenta et al.
BIOMOLECULAR ENGINEERING (2002)
HIF-1 and tumor progression: pathophysiology and therapeutics
GL Semenza
TRENDS IN MOLECULAR MEDICINE (2002)
Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer
DM Brizel et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)
Microenvironment-induced cancer metastasis
EK Rofstad
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2000)
Share Paper
